Global Nephrology Drugs Market By Drug Class (ACE Inhibitors, Calcium Channel Blocker, Beta Blockers, Diuretics, and Others), By Route of Administration (Oral, Parenteral, and Others), By Distribution Channel (Hospital Pharmacy, Retail Pharmacy, Online Pharmacy, and Others) Region and Companies – Industry Segment Outlook, Market Assessment, Competition Scenario, Trends and Forecast 2024-2033
- Published date: Sep 2024
- Report ID: 129655
- Number of Pages: 389
- Format:
-
keyboard_arrow_up
-
-
- Johnson & Johnson Inc.
- Teva Pharmaceuticals Industries Limited
- GlaxoSmithKline PLC
- Amgen Inc.
- F-Hoffmann La Roche
- Akebia Therapeutics Inc.
- AstraZeneca Plc Company Profile
- FibroGen Inc.
- AbbVie Inc. Company Profile
- Pfizer Inc Company Profile
- Other Key Players
- settingsSettings
Our Clients
- 129655
- Sep 2024
Trusted by more than 17382 organizations globally
✖
Request a Sample Report
We'll get back to you as quickly as possible
|
Single User
$6,000
$3,999
USD / per unit
save 24%
|
Multi User
$8,000
$5,999
USD / per unit
save 28%
|
Corporate User
$10,000
$6,999
USD / per unit
save 32%
|
|
|---|---|---|---|
| e-Access | |||
| Report Library Access | |||
| Data Set (Excel) | |||
| Company Profile Library Access | |||
| Interactive Dashboard | |||
| Free Custumization | No | up to 10 hrs work | up to 30 hrs work |
| Accessibility | 1 User | 2-5 User | Unlimited |
| Analyst Support | up to 20 hrs | up to 40 hrs | up to 50 hrs |
| Benefit | Up to 20% off on next purchase | Up to 25% off on next purchase | Up to 30% off on next purchase |
| Buy Now ($ 3,999) | Buy Now ($ 5,999) | Buy Now ($ 6,999) |
